Design Therapeutics Reports Third Quarter 2023 Financial Res

Seasoned Biotech Executive Pratik Shah Appointed as Chief Executive Officer to Lead Company Turnaround Current Cash and Securities of ~$290M Support Extended Five-Year Operating Runway Through 2028 ...

Related Keywords

United States , Chelcie Lister , Pratik Shah , Strategic Communications , Nasdaq , Verge Scientific Communications , Company Turnaround , Design Therapeutics Inc , Exchange Commission , Seasoned Biotech Executive Pratik Shah Appointed , Chief Executive Officer , Lead Company , Corporate Strategy , Realignment Towards Long Term Growth , Additional Details , Operating Runway , Private Securities Litigation Reform Act , Quarterly Report , Months Ended September , Markets ,